Can emotional memory retrieval just prior to electroconvulsive therapy sessions improve the outcome of ECT in patients with major depressive disorder?
SSRI use after intracerebral hemorrhage may resolve depression symptoms, but also increases patients’ risk for recurrent stroke.
A substantial percentage of women with peripheral artery disease reported having depressive symptoms.
Investigators examined the mRNA signature foundation associated with the pro-inflammatory phenotype of depression, along with the differential signatures linked to depression subtypes and the impact of antidepressant agents.
This study is the first quantitative verification of a link between engagement in physical activity and resilience, positive affect, and depressive symptoms in older adults within COVID-19 restrictions.
Higher childhood neighborhood quality and childhood friendliness scores have been shown to be significantly associated with a lower risk for the development of depressive symptoms in adults.
Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.
Depression, a significant cause of disability in the United States, is largely managed by primary care providers; therefore, understanding how these clinicians manage depression is an important step toward identifying opportunities for improvement.
A pooled analysis evaluated reductions in migraine and headache days among patients with chronic migraine and comorbid depression in 2 placebo-controlled, phase 3 trials of fremanezumab.
Treatment rates for patients with major depressive disorder with an elevated PHQ-9 score were characterized in this study.
